Last reviewed · How we verify
Liver cell carcinoma
Approved treatments
- Avastin · Washington University School of Medicine
- Cometriq · Exelixis
Cometriq blocks the VEGFR2 pathway to prevent tumor growth and angiogenesis. - Nexavar · Bayer
- Imfinzi · AstraZeneca
Imfinzi works by blocking the PD-L1 protein, allowing the immune system to recognize and attack cancer cells. - Bevacizumab · Roche
Bevacizumab binds VEGF and prevents interaction with endothelial cell receptors Flt-1 and KDR. - Lenvima · Eisai
Lenvima works by blocking the activity of a specific protein called Ret, which is involved in the growth and spread of cancer cells. - Nexavar · Fujian Medical University
- Cometriq · Exelixis Inc
Cometriq works by blocking the activity of vascular endothelial growth factor receptor 2, a protein involved in tumor growth and angiogenesis. - Imfinzi · University Medical Center Groningen
- IMJUDO · ASTRAZENECA AB
- Imjudo · AstraZeneca
Tremelimumab-actl binds to CTLA-4, blocking its interaction with CD80 and CD86, thereby enhancing T-cell activation and reducing tumor growth. - Tecentriq · Roche
Tecentriq works by blocking a protein called PD-L1, which helps cancer cells hide from the immune system. - Avastin · Roche
Bevacizumab works by binding to VEGF-A, preventing it from promoting the growth of new blood vessels that feed tumors. - Cyramza · Eli Lilly
Cyramza blocks the VEGFR2 receptor, which is involved in cancer cell growth and spread. - Stivarga · Bayer
Stivarga blocks the activity of enzymes involved in tumor growth and angiogenesis.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Liver cell carcinoma patent landscape — cliff calendar, originator estates, attackable patents
- Liver cell carcinoma treatment landscape brief
- Liver cell carcinoma treatment updates RSS
Frequently asked questions about Liver cell carcinoma
What drugs treat Liver cell carcinoma?
Tracked treatments include Avastin, Cometriq, Nexavar, Imfinzi, Bevacizumab, Lenvima, IMJUDO, Imjudo.
What is the treatment for Liver cell carcinoma?
Standard treatment for Liver cell carcinoma includes Avastin, Cometriq, Nexavar, Imfinzi, Bevacizumab. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Liver cell carcinoma patent cliff · Liver cell carcinoma CI report
- Treatment: Avastin · Washington University School of Medicine
- Treatment: Cometriq · Exelixis
- Treatment: Nexavar · Bayer
- Treatment: Imfinzi · AstraZeneca
- Treatment: Bevacizumab · Roche
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing